PURPOSE: Bilateral frontoparietal polymicrogyria (BFPP) has been reported in sporadic patients and in recessive pedigrees. Eleven mutations in GPR56, a gene encoding an evolutionarily dynamic G-protein-coupled receptor, have been identified in 29 patients from 18 families. The clinical features of BFPP include severe mental retardation, motor and language impairment, and epilepsy. No detailed description of the epilepsy is available for the patients reported to date. We report three consanguineous families in which four affected individuals with BFPP and GPR56 mutations had Lennox-Gastaut syndrome. METHODS: Family studies, brain magnetic resonance imaging (MRI), electroencephalography (EEG)-video recordings, and mutation analysis. RESULTS: In Family 1, with one affected proband, we found an R565W change in the second extracellular loop of GPR56, involving a highly conserved aminoacidic residue. In Family 2, with one affected proband, we found an R79X change affecting the protein N-terminus and predicted to cause a premature truncation with loss of the G-protein-coupled receptor proteolytic site. In family 3, with two affected siblings, we found an R33P substitution in the protein N-terminus, involving a highly conserved aminoacidic residue. Epilepsy, present in all four patients, had started between ages 1 and 8 years, with infantile spasms in one patient and with de novo Lennox-Gastaut syndrome in the remaining three. All patients had Lennox-Gastaut syndrome when last observed, at ages 13 to 32 years. DISCUSSION: Several genes, when mutated, can cause malformations of cortical development that have been associated with the Lennox-Gastaut syndrome. BFPP caused by GPR56 mutations represents an additional, although rare, genetically determined cause of Lennox-Gastaut syndrome.
PURPOSE: Bilateral frontoparietal polymicrogyria (BFPP) has been reported in sporadic patients and in recessive pedigrees. Eleven mutations in GPR56, a gene encoding an evolutionarily dynamic G-protein-coupled receptor, have been identified in 29 patients from 18 families. The clinical features of BFPP include severe mental retardation, motor and language impairment, and epilepsy. No detailed description of the epilepsy is available for the patients reported to date. We report three consanguineous families in which four affected individuals with BFPP and GPR56 mutations had Lennox-Gastaut syndrome. METHODS: Family studies, brain magnetic resonance imaging (MRI), electroencephalography (EEG)-video recordings, and mutation analysis. RESULTS: In Family 1, with one affected proband, we found an R565W change in the second extracellular loop of GPR56, involving a highly conserved aminoacidic residue. In Family 2, with one affected proband, we found an R79X change affecting the protein N-terminus and predicted to cause a premature truncation with loss of the G-protein-coupled receptor proteolytic site. In family 3, with two affected siblings, we found an R33P substitution in the protein N-terminus, involving a highly conserved aminoacidic residue. Epilepsy, present in all four patients, had started between ages 1 and 8 years, with infantile spasms in one patient and with de novo Lennox-Gastaut syndrome in the remaining three. All patients had Lennox-Gastaut syndrome when last observed, at ages 13 to 32 years. DISCUSSION: Several genes, when mutated, can cause malformations of cortical development that have been associated with the Lennox-Gastaut syndrome. BFPP caused by GPR56 mutations represents an additional, although rare, genetically determined cause of Lennox-Gastaut syndrome.
Authors: M Liu; R M Parker; K Darby; H J Eyre; N G Copeland; J Crawford; D J Gilbert; G R Sutherland; N A Jenkins; H Herzog Journal: Genomics Date: 1999-02-01 Impact factor: 5.736
Authors: Chris Englund; Andy Fink; Charmaine Lau; Diane Pham; Ray A M Daza; Alessandro Bulfone; Tom Kowalczyk; Robert F Hevner Journal: J Neurosci Date: 2005-01-05 Impact factor: 6.167
Authors: Patrice Roll; Gabrielle Rudolf; Sandrine Pereira; Barbara Royer; Ingrid E Scheffer; Annick Massacrier; Maria-Paola Valenti; Nathalie Roeckel-Trevisiol; Sarah Jamali; Christophe Beclin; Caroline Seegmuller; Marie-Noëlle Metz-Lutz; Arnaud Lemainque; Marc Delepine; Christophe Caloustian; Anne de Saint Martin; Nadine Bruneau; Danièle Depétris; Marie-Geneviève Mattéi; Elisabeth Flori; Andrée Robaglia-Schlupp; Nicolas Lévy; Bernd A Neubauer; Rivka Ravid; Christian Marescaux; Samuel F Berkovic; Edouard Hirsch; Mark Lathrop; Pierre Cau; Pierre Szepetowski Journal: Hum Mol Genet Date: 2006-02-23 Impact factor: 6.150
Authors: R Guerrini; F Dubeau; O Dulac; A J Barkovich; R Kuzniecky; C Fett; M Jones-Gotman; R Canapicchi; H Cross; D Fish; P Bonanni; I Jambaqué; F Andermann Journal: Ann Neurol Date: 1997-01 Impact factor: 10.422
Authors: Pasquale Parisi; Alberto Verrotti; Maria Chiara Paolino; Rosa Castaldo; Filomena Ianniello; Alessandro Ferretti; Francesco Chiarelli; Maria Pia Villa Journal: Ital J Pediatr Date: 2011-12-19 Impact factor: 2.638
Authors: Humaira Aziz Sawal; Ricardo Harripaul; Anna Mikhailov; Kayla Vleuten; Farooq Naeem; Tanveer Nasr; Muhammad Jawad Hassan; John B Vincent; Muhammad Ayub; Muhammad Arshad Rafiq Journal: J Pediatr Genet Date: 2017-12-21
Authors: Vincent Strehlow; Marielle E M Swinkels; Rhys H Thomas; Nora Rapps; Steffen Syrbe; Thomas Dorn; Johannes R Lemke Journal: Mol Syndromol Date: 2016-08-24
Authors: Melissa P Wu; Jamie R Doyle; Brenda Barry; Ariane Beauvais; Anete Rozkalne; Xianhua Piao; Michael W Lawlor; Alan S Kopin; Christopher A Walsh; Emanuela Gussoni Journal: FEBS J Date: 2013-10-08 Impact factor: 5.542
Authors: Y Nakata; A J Barkovich; M Wahl; Z Strominger; R J Jeremy; M Wakahiro; P Mukherjee; E H Sherr Journal: AJNR Am J Neuroradiol Date: 2009-02-26 Impact factor: 3.825